🚀 VC round data is live in beta, check it out!
Largest HealthTech Public Companies in the US
Benchmark revenue and EBITDA valuation multiples for public comps like
Johnson & Johnson, UnitedHealth Group, Abbott, Thermo Fisher Scientific and Intuitive Surgical.
 | $240 | +53% | $577B | $605B | 6.3x | 17.0x | ||
| $295 | -28% | $267B | $317B | 0.7x | 11.9x | ||
| $114 | -13% | $198B | $203B | 4.5x | 16.8x | ||
| $491 | +15% | $183B | $212B | 4.7x | 18.7x | ||
| $496 | -4% | $176B | $170B | 16.3x | 37.7x | ||
| $387 | +4% | $148B | $160B | 6.2x | 21.7x | ||
| $206 | +3% | $146B | $161B | 6.5x | 20.5x | ||
| $76 | -26% | $113B | $123B | 5.9x | 18.9x | ||
| $87 | +2% | $111B | $131B | 3.6x | 12.9x | ||
| $637 | +47% | $51B | $51B | 11.7x | 33.3x | ||
| $81 | +7% | $47B | $43B | 6.9x | 22.8x | ||
| $358 | -36% | $37B | $46B | 5.7x | 14.3x | ||
| $118 | +10% | $33B | $35B | 4.9x | 16.9x | ||
| $23 | -14% | $33B | $32B | 5.8x | 15.1x | ||
| $70 | +0% | $32B | $38B | 1.8x | 10.2x | ||
| $304 | -13% | $30B | $31B | 7.7x | 22.5x | ||
| $173 | +12% | $29B | $43B | 2.6x | 11.2x | ||
| $205 | +36% | $29B | $28B | 11.7x | (107.3x) | ||
| $174 | -26% | $28B | $22B | 6.7x | 14.8x | ||
| $74 | +3% | $28B | $28B | 5.8x | 19.6x | ||
| $1,260 | +18% | $26B | $28B | 6.8x | 21.7x | ||
| $274 | +14% | $23B | $29B | 2.0x | 11.7x | ||
| $198 | +11% | $22B | $28B | 2.5x | 12.5x | ||
| $220 | -2% | $22B | $23B | 3.9x | 13.9x | ||
| $104 | +127% | $20B | $21B | 6.3x | 47.1x | ||
| $195 | -18% | $19B | $21B | 6.1x | 19.6x | ||
| $91 | -12% | $18B | $25B | 2.9x | 8.9x | ||
| $190 | +33% | $17B | $27B | 1.2x | 5.8x | ||
| $204 | -19% | $14B | $15B | 5.1x | 21.5x | ||
| $498 | +62% | $14B | $14B | 5.3x | 24.1x | ||
| $103 | +43% | $14B | $13B | 4.5x | 14.1x | ||
| $94 | +99% | $12B | $13B | 12.1x | (61.3x) | ||
| $171 | -2% | $12B | $11B | 2.7x | 10.2x | ||
| $63 | -4% | $11B | $15B | 1.8x | 6.9x | ||
| $49 | +8% | $10B | $11B | 5.0x | 13.7x | ||
| $89 | -5% | $10B | $12B | 4.3x | 14.4x | ||
| $53 | +3% | $10B | $10B | 7.4x | 717.3x | ||
| $179 | +11% | $9B | $10B | 6.3x | 21.3x | ||
| $114 | -25% | $9B | $12B | 1.5x | 7.7x | ||
| $152 | -53% | $8B | $4B | 0.1x | 4.0x | ||
| $278 | +15% | $7B | $7B | 2.8x | 16.0x | ||
| $113 | -15% | $7B | $8B | 1.1x | 6.4x | ||
| $83 | -3% | $7B | $8B | 5.8x | 13.4x | ||
| $121 | +29% | $7B | $7B | 12.8x | (358.3x) | ||
| $75 | +44% | $6B | $7B | 3.2x | 21.8x | ||
| $37 | -8% | $6B | $7B | 2.1x | 12.8x | ||
| $123 | -10% | $5B | $8B | 3.8x | 13.3x | ||
| $158 | +21% | $5B | $5B | 1.9x | 4.5x | ||
| $76 | -27% | $5B | $5B | 3.5x | 9.6x | ||
| $26 | -29% | $5B | $6B | 5.6x | 13.3x | ||
| $19 | +17% | $5B | $6B | 5.7x | 22.7x | ||
| $26 | -55% | $5B | $4B | 6.2x | 11.3x | ||
| $77 | -19% | $5B | $5B | 3.2x | 12.8x | ||
| $26 | +61% | $4B | $5B | 1.7x | 12.1x | ||
| $117 | -2% | $4B | $4B | 4.1x | 17.9x | ||
| $14 | +7% | $4B | $2B | 0.1x | (15.4x) | ||
| $128 | +20% | $4B | $4B | 5.5x | 54.8x | ||
| $53 | +82% | $4B | $4B | 4.5x | (37.9x) | ||
| $14 | -- | $4B | $4B | — | — | ||
| $19 | +12% | $4B | $4B | 0.8x | 29.2x | ||
| $70 | +90% | $4B | $4B | 2.6x | 11.3x | ||
| $16 | -50% | $4B | $4B | 1.7x | 13.5x | ||
| $105 | +14% | $4B | $4B | 5.7x | 22.6x | ||
| $6 | -40% | $4B | $5B | 4.2x | 10.1x | ||
| $142 | +4% | $4B | $5B | 2.1x | 11.1x | ||
| $24 | +3% | $3B | $3B | 1.1x | 19.1x | ||
| $86 | -32% | $3B | $4B | 2.3x | 10.6x | ||
| $64 | +1% | $3B | $4B | 2.9x | 9.2x | ||
| $36 | +19% | $3B | $3B | 4.7x | 17.5x | ||
| $52 | -52% | $3B | $2B | — | — | ||
| $106 | +17% | $2B | $2B | 8.7x | 28.7x | ||
| $79 | +19% | $2B | $2B | 4.9x | 61.3x | ||
| $12 | +27% | $2B | $3B | 4.4x | 14.5x | ||
| $52 | +50% | $2B | $1B | 8.1x | (3.4x) | ||
| $65 | -59% | $2B | $2B | 1.7x | 7.6x | ||
| $39 | +63% | $2B | $2B | 4.5x | 21.7x | ||
| $204 | -2% | $2B | $2B | 2.8x | 13.8x | ||
| $34 | +9% | $2B | $2B | 1.3x | 10.8x | ||
| $31 | +4% | $2B | $1B | 2.6x | 21.7x | ||
| $31 | +88% | $2B | $2B | 6.6x | 56.3x | ||
| $26 | -26% | $1B | $3B | 1.3x | 7.0x | ||
| $18 | -23% | $1B | $1B | 0.9x | 5.2x | ||
| $24 | -56% | $1B | $1B | 3.4x | (26.0x) | ||
| $105 | +101% | $1B | $1B | 15.0x | 46.1x | ||
| $1 | -86% | $1B | $1B | — | — | ||
| $19 | +14% | $1B | $1B | 1.4x | (81.7x) | ||
| $19 | +11% | $1B | $1B | 1072.8x | (22.6x) | ||
| $83 | +17% | $1B | $2B | 1.9x | 15.8x | ||
| $9 | +8% | $1B | $3B | 0.9x | 4.8x | ||
| $11 | -42% | $1B | $1B | 1.5x | (36.4x) | ||
| $17 | -38% | $1B | $4B | 1.4x | 6.3x | ||
| $26 | -30% | $1B | $861M | 0.6x | 11.6x | ||
| $2 | -39% | $1B | $754M | 0.3x | 24.6x | ||
| $35 | -29% | $1B | $2B | 1.4x | 6.8x | ||
| $8 | +25% | $1B | $1B | 1.7x | 27.5x | ||
| $19 | +11% | $964M | $798M | 2.0x | 23.8x | ||
| $13 | -49% | $962M | $676M | 2.6x | (5.1x) | ||
| $4 | +62% | $957M | $834M | 8.1x | (32.0x) | ||
| $19 | +5% | $948M | $795M | 3.1x | 178.7x | ||
| $5 | -28% | $916M | $1B | 0.5x | 4.4x |
Financial data powered by FactSet and Morningstar. Valuation multiples as of last 12 months. For more data, start your free trial here.
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.